March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Secretion Of Vascular Growth Factors/inflammatory Cytokines By Rpe Is Inhibited By Ranibizumab
Author Affiliations & Notes
  • Murugeswari Ponnalagu
    Immunology and Cell Biology, Aravind Medical Research Foundation, Madurai, India
  • Alan W. Stitt
    Centre for Vision & Vascular Science, Queens University Belfast, Belfast, United Kingdom
  • Kim Ramasamy
    Vitreous and Retina Service, Aravind Eye Hospital, Madurai, India
  • Muthukkaruppan Veerappan
    Immunology and Cell Biology, Aravind Medical Research Foundation, Madurai, India
  • Footnotes
    Commercial Relationships  Murugeswari Ponnalagu, None; Alan W. Stitt, None; Kim Ramasamy, None; Muthukkaruppan Veerappan, None
  • Footnotes
    Support  Aravind Medical Research Foundation
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1671. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Murugeswari Ponnalagu, Alan W. Stitt, Kim Ramasamy, Muthukkaruppan Veerappan; Secretion Of Vascular Growth Factors/inflammatory Cytokines By Rpe Is Inhibited By Ranibizumab. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1671.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To understand the effects of VEGF and IL-6 neutralization on the secretion of cytokines and angiogenic growth factors by ARPE-19 cells in vitro

Methods: : ARPE-19 cells were exposed to different concentrations of anti-VEGF antibody (ranibizumab; RZB) (0.125 mg/ml and 0.25 mg/ml) or anti-IL6 antibody (0.05 µg/ml, 0.1 µg/ml and 0.2 µg/ml) for 24 hrs. The conditioned medium was analyszd for 12 cytokines (IL-1α,IL1-β,IL-2, IL-4,IL-6,IL-8,IL-10,IFN-γ,TNF-α,VEGF,MCP-1 and EGF) by Cytokine Biochip Array. mRNA expression was also studied using SYBR green real-time PCR analysis.

Results: : Among the cytokines measured, significant levels of VEGF (687.2±9.3pg/ml), IL-6 (25.2±0.3pg/ml) IL-2 (5.1±1.2pg/ml), IFN-γ (22.4±4.7pg/ml), MCP-1(>840pg/ml) and IL-8(253.6±5.6pg/ml) were observed in 24 hrs culture supernatant. A significant reduction of VEGF (P<0.001) and also IL-6 and IL-2 (P<0.001) was observed on treatment with RZB. After 24hrs treatment, cells were cultured without RZB for 48 hrs and still VEGF was not detected in the conditioned medium. Moreover, neutralizing antibody to IL-6 reduced the secreted levels of VEGF (P<0.001) in the cell supernatant. However, subsequent culturing without anti-IL6 antibody did not affect the secretion of VEGF by ARPE 19 cells. These antibodies did not influence the secretion of other cytokines (IFN-γ and MCP-1). No remarkable changes in the mRNA expression of VEGF and IL-6 were found when treated with antibodies.

Conclusions: : Anti-VEGF antibody reduced the secretion of IL-6 in addition to VEGF. Neutralizing IL-6 antibody also reduced VEGF expression by ARPE-19 cells. Further studies are required to understand the molecular mechanism between cytokines and angiogenic growth factor regulation in RPE.

Keywords: retinal pigment epithelium • age-related macular degeneration • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×